The DOI matches its Crossref record; 240 of the 240 references it cites were found in a registry or an index.
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Reck, M., Rodríguez-Abreu, D., Robinson, A. G., Hui, R., Csőszi, T., Fülöp, A., Gottfried, M., Peled, N., Tafreshi, A., Cuffe, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606774 · Cited by 10,089
Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
Borghaei, H., Paz-Ares, L., Horn, L., Spigel, D. R., Steins, M., Ready, N. E., Chow, L. Q., Vokes, E. E., Felip, E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507643 · Cited by 9,335
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Brahmer, J., Reckamp, K. L., Baas, P., Crinò, L., Eberhardt, W. E. E., Poddubskaya, E., Antonia, S., Pluzanski, A., Vokes, E. E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504627 · Cited by 8,447
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
Herbst, R. S., Baas, P., Kim, D.-W., Felip, E., Pérez-Gracia, J. L., Han, J.-Y., Molina, J., Kim, J.-H., Arvis, C. D., Ahn, M.-J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01281-7 · Cited by 6,449
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Rittmeyer, A., Barlesi, F., Waterkamp, D., Park, K., Ciardiello, F., von Pawel, J., Gadgeel, S. M., Hida, T., Kowalski, D. M., Dols, M. C., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32517-x · Cited by 4,675
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
Engelman, J. A., Zejnullahu, K., Mitsudomi, T., Song, Y., Hyland, C., Park, J. O., Lindeman, N., Gale, C.-M., Zhao, X., Christensen, J., et al. (2007) · Science · doi:10.1126/science.1141478 · Cited by 4,496
Self-citationAnaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y.-J., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S.-H. I., Dezube, B. J., Jänne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,446
Self-citationCell-free nucleic acids as biomarkers in cancer patients
Schwarzenbach, H., Hoon, D. S. B., & Pantel, K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3066 · Cited by 2,891
Shigematsu, H., Lin, L., Takahashi, T., Nomura, M., Suzuki, M., Wistuba, I. I., Fong, K. M., Lee, H., Toyooka, S., Shimizu, N., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji055 · Cited by 2,377
Cross, D. A. E., Ashton, S. E., Ghiorghiu, S., Eberlein, C., Nebhan, C. A., Spitzler, P. J., Orme, J. P., Finlay, M. R. V., Ward, R. A., Mellor, M. J., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0337 · Cited by 2,246
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
Jänne, P. A., Yang, J. C.-H., Kim, D.-W., Planchard, D., Ohe, Y., Ramalingam, S. S., Ahn, M.-J., Kim, S.-W., Su, W.-C., Horn, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411817 · Cited by 2,116
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
Li, M. M., Datto, M., Duncavage, E. J., Kulkarni, S., Lindeman, N. I., Roy, S., Tsimberidou, A. M., Vnencak-Jones, C. L., Wolff, D. J., Younes, A., et al. (2017) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2016.10.002 · Cited by 2,030
Self-citationCrizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
Shaw, A. T., Ou, S.-H. I., Bang, Y.-J., Camidge, D. R., Solomon, B. J., Salgia, R., Riely, G. J., Varella-Garcia, M., Shapiro, G. I., Costa, D. B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406766 · Cited by 1,964
Self-citationClinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
Shaw, A. T., Yeap, B. Y., Mino-Kenudson, M., Digumarthy, S. R., Costa, D. B., Heist, R. S., Solomon, B., Stubbs, H., Admane, S., McDermott, U., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.6993 · Cited by 1,870
Self-citationBean, J., Brennan, C., Shih, J.-Y., Riely, G., Viale, A., Wang, L., Chitale, D., Motoi, N., Szoke, J., Broderick, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710370104 · Cited by 1,598
Self-citationROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
Bergethon, K., Shaw, A. T., Ignatius Ou, S.-H., Katayama, R., Lovly, C. M., McDonald, N. T., Massion, P. P., Siwak-Tapp, C., Gonzalez, A., Fang, R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.6345 · Cited by 1,555
Targeting MET in cancer: rationale and progress
Gherardi, E., Birchmeier, W., Birchmeier, C., & Woude, G. V. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3205 · Cited by 1,423
Andrews, J., Guyatt, G., Oxman, A. D., Alderson, P., Dahm, P., Falck-Ytter, Y., Nasser, M., Meerpohl, J., Post, P. N., Kunz, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.03.013 · Cited by 1,416
Planchard, D., Smit, E. F., Groen, H. J. M., Mazieres, J., Besse, B., Helland, Å., Giannone, V., D'Amelio, A. M., Zhang, P., Mookerjee, B., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30679-4 · Cited by 1,360
RET, ROS1 and ALK fusions in lung cancer
Takeuchi, K., Soda, M., Togashi, Y., Suzuki, R., Sakata, S., Hatano, S., Asaka, R., Hamanaka, W., Ninomiya, H., Uehara, H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2658 · Cited by 1,320
Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J.-S., Squire, J., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318290868f · Cited by 1,280
Self-citationMET signalling: principles and functions in development, organ regeneration and cancer
Trusolino, L., Bertotti, A., & Comoglio, P. M. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3012 · Cited by 1,240
Anchored multiplex PCR for targeted next-generation sequencing
Zheng, Z., Liebers, M., Zhelyazkova, B., Cao, Y., Panditi, D., Lynch, K. D., Chen, J., Robinson, H. E., Shim, H. S., Chmielecki, J., et al. (2014) · Nature Medicine · doi:10.1038/nm.3729 · Cited by 915
Shaw, A. T., Yeap, B. Y., Solomon, B. J., Riely, G. J., Gainor, J., Engelman, J. A., Shapiro, G. I., Costa, D. B., Ou, S.-H. I., Butaney, M., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70232-7 · Cited by 899
Self-citationPlanchard, D., Besse, B., Groen, H. J. M., Souquet, P.-J., Quoix, E., Baik, C. S., Barlesi, F., Kim, T. M., Mazieres, J., Novello, S., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30146-2 · Cited by 888
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
Lipson, D., Capelletti, M., Yelensky, R., Otto, G., Parker, A., Jarosz, M., Curran, J. A., Balasubramanian, S., Bloom, T., Brennan, K. W., et al. (2012) · Nature Medicine · doi:10.1038/nm.2673 · Cited by 869
Oxnard, G. R., Thress, K. S., Alden, R. S., Lawrance, R., Paweletz, C. P., Cantarini, M., Yang, J. C.-H., Barrett, J. C., & Jänne, P. A. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.7162 · Cited by 850
KIF5B-RET fusions in lung adenocarcinoma
Kohno, T., Ichikawa, H., Totoki, Y., Yasuda, K., Hiramoto, M., Nammo, T., Sakamoto, H., Tsuta, K., Furuta, K., Shimada, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2644 · Cited by 834
Frampton, G. M., Ali, S. M., Rosenzweig, M., Chmielecki, J., Lu, X., Bauer, T. M., Akimov, M., Bufill, J. A., Lee, C., Jentz, D., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0285 · Cited by 796
Oxnard, G. R., Paweletz, C. P., Kuang, Y., Mach, S. L., O'Connell, A., Messineo, M. M., Luke, J. J., Butaney, M., Kirschmeier, P., Jackman, D. M., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2482 · Cited by 786
Guidelines for Validation of Next-Generation Sequencing–Based Oncology Panels
Jennings, L. J., Arcila, M. E., Corless, C., Kamel-Reid, S., Lubin, I. M., Pfeifer, J., Temple-Smolkin, R. L., Voelkerding, K. V., & Nikiforova, M. N. (2017) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2017.01.011 · Cited by 743
Self-citationLengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Jiang, P., Chan, C. W. M., Chan, K. C. A., Cheng, S. H., Wong, J., Wong, V. W.-S., Wong, G. L. H., Chan, S. L., Mok, T. S. K., Chan, H. L. Y., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500076112 · Cited by 738
Riely, G. J., Pao, W., Pham, D., Li, A. R., Rizvi, N., Venkatraman, E. S., Zakowski, M. F., Kris, M. G., Ladanyi, M., & Miller, V. A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1846 · Cited by 731
Self-citationTakezawa, K., Pirazzoli, V., Arcila, M. E., Nebhan, C. A., Song, X., de Stanchina, E., Ohashi, K., Janjigian, Y. Y., Spitzler, P. J., Melnick, M. A., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0108 · Cited by 710
Self-citationAwad, M. M., Oxnard, G. R., Jackman, D. M., Savukoski, D. O., Hall, D., Shivdasani, P., Heng, J. C., Dahlberg, S. E., Jänne, P. A., Verma, S., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.4600 · Cited by 693
Self-citationRodig, S. J., Mino-Kenudson, M., Dacic, S., Yeap, B. Y., Shaw, A., Barletta, J. A., Stubbs, H., Law, K., Lindeman, N., Mark, E., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0802 · Cited by 678
Self-citationLibrary construction for next-generation sequencing: Overviews and challenges
Head, S. R., Komori, H. K., LaMere, S. A., Whisenant, T., Van Nieuwerburgh, F., Salomon, D. R., & Ordoukhanian, P. (2014) · BioTechniques · doi:10.2144/000114133 · Cited by 669
Jänne, P. A., Shaw, A. T., Pereira, J. R., Jeannin, G., Vansteenkiste, J., Barrios, C., Franke, F. A., Grinsted, L., Zazulina, V., Smith, P., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70489-8 · Cited by 655
Dogan, S., Shen, R., Ang, D. C., Johnson, M. L., D'Angelo, S. P., Paik, P. K., Brzostowski, E. B., Riely, G. J., Kris, M. G., Zakowski, M. F., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3265 · Cited by 639
Self-citationMassarelli, E., Varella-Garcia, M., Tang, X., Xavier, A. C., Ozburn, N. C., Liu, D. D., Bekele, B. N., Herbst, R. S., & Wistuba, I. I. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3043 · Cited by 597
Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma
Riely, G. J., Kris, M. G., Rosenbaum, D., Marks, J., Li, A., Chitale, D. A., Nafa, K., Riedel, E. R., Hsu, M., Pao, W., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0646 · Cited by 578
Self-citationPaik, P. K., Drilon, A., Fan, P.-D., Yu, H., Rekhtman, N., Ginsberg, M. S., Borsu, L., Schultz, N., Berger, M. F., Rudin, C. M., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1467 · Cited by 575
Self-citationClinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Harboring BRAF Mutations
Marchetti, A., Felicioni, L., Malatesta, S., Grazia Sciarrotta, M., Guetti, L., Chella, A., Viola, P., Pullara, C., Mucilli, F., & Buttitta, F. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.9638 · Cited by 568
High Fragmentation Characterizes Tumour-Derived Circulating DNA
Mouliere, F., Robert, B., Arnau Peyrotte, E., Del Rio, M., Ychou, M., Molina, F., Gongora, C., & Thierry, A. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023418 · Cited by 567
Cappuzzo, F., Marchetti, A., Skokan, M., Rossi, E., Gajapathy, S., Felicioni, L., del Grammastro, M., Sciarrotta, M. G., Buttitta, F., Incarbone, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.1635 · Cited by 557
RET Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non–Small-Cell Lung Cancer
Wang, R., Hu, H., Pan, Y., Li, Y., Ye, T., Li, C., Luo, X., Wang, L., Li, H., Zhang, Y., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.1477 · Cited by 546
Optimization of Dosing for EGFR-Mutant Non–Small Cell Lung Cancer with Evolutionary Cancer Modeling
Chmielecki, J., Foo, J., Oxnard, G. R., Hutchinson, K., Ohashi, K., Somwar, R., Wang, L., Amato, K. R., Arcila, M., Sos, M. L., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002356 · Cited by 525
Self-citationArcila, M. E., Chaft, J. E., Nafa, K., Roy-Chowdhuri, S., Lau, C., Zaidinski, M., Paik, P. K., Zakowski, M. F., Kris, M. G., & Ladanyi, M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0912 · Cited by 505
Self-citationThress, K. S., Brant, R., Carr, T. H., Dearden, S., Jenkins, S., Brown, H., Hammett, T., Cantarini, M., & Barrett, J. C. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.10.004 · Cited by 493
Douillard, J.-Y., Shepherd, F. A., Hirsh, V., Mok, T., Socinski, M. A., Gervais, R., Liao, M.-L., Bischoff, H., Reck, M., Sellers, M. V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.3030 · Cited by 492
Drilon, A., Rekhtman, N., Arcila, M., Wang, L., Ni, A., Albano, M., Van Voorthuysen, M., Somwar, R., Smith, R. S., Montecalvo, J., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30562-9 · Cited by 484
Self-citationSpigel, D. R., Ervin, T. J., Ramlau, R. A., Daniel, D. B., Goldschmidt, J. H., Blumenschein, G. R., Krzakowski, M. J., Robinet, G., Godbert, B., Barlesi, F., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.4189 · Cited by 480
Mok, T., Wu, Y.-L., Lee, J. S., Yu, C.-J., Sriuranpong, V., Sandoval-Tan, J., Ladrera, G., Thongprasert, S., Srimuninnimit, V., Liao, M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2594 · Cited by 468
Response to Cabozantinib in Patients with RET Fusion-Positive Lung Adenocarcinomas
Drilon, A., Wang, L., Hasanovic, A., Suehara, Y., Lipson, D., Stephens, P., Ross, J., Miller, V., Ginsberg, M., Zakowski, M. F., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0035 · Cited by 464
Self-citationLindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J.-S., Squire, J., et al. (2013) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.03.001 · Cited by 462
Self-citationEngelman, J. A., Mukohara, T., Zejnullahu, K., Lifshits, E., Borras, A. M., Gale, C.-M., Naumov, G. N., Yeap, B. Y., Jarrell, E., Sun, J., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28656 · Cited by 456
Planchard, D., Kim, T. M., Mazieres, J., Quoix, E., Riely, G., Barlesi, F., Souquet, P.-J., Smit, E. F., Groen, H. J. M., Kelly, R. J., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)00077-2 · Cited by 453
Tong, J. H., Yeung, S. F., Chan, A. W. H., Chung, L. Y., Chau, S. L., Lung, R. W. M., Tong, C. Y., Chow, C., Tin, E. K. Y., Yu, Y. H., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2061 · Cited by 449
Douillard, J.-Y., Ostoros, G., Cobo, M., Ciuleanu, T., Cole, R., McWalter, G., Walker, J., Dearden, S., Webster, A., Milenkova, T., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000263 · Cited by 448
Inamura, K., Takeuchi, K., Togashi, Y., Hatano, S., Ninomiya, H., Motoi, N., Mun, M.-Y., Sakao, Y., Okumura, S., Nakagawa, K., et al. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.2 · Cited by 445
Activating mutations for the Met tyrosine kinase receptor in human cancer
Jeffers, M., Schmidt, L., Nakaigawa, N., Webb, C. P., Weirich, G., Kishida, T., Zbar, B., & Vande Woude, G. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11445 · Cited by 442
Ou, S.-H. I., Kwak, E. L., Siwak-Tapp, C., Dy, J., Bergethon, K., Clark, J. W., Camidge, D. R., Solomon, B. J., Maki, R. G., Bang, Y.-J., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31821528d3 · Cited by 432
Self-citationLindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J.-S., Squire, J., et al. (2013) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2012-0720-oa · Cited by 426
Self-citationMino-Kenudson, M., Chirieac, L. R., Law, K., Hornick, J. L., Lindeman, N., Mark, E. J., Cohen, D. W., Johnson, B. E., Jänne, P. A., Iafrate, A. J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2845 · Cited by 423
Self-citationGatzemeier, U., Groth, G., Butts, C., Van Zandwijk, N., Shepherd, F., Ardizzoni, A., Barton, C., Ghahramani, P., & Hirsh, V. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh031 · Cited by 388
Cardarella, S., Ogino, A., Nishino, M., Butaney, M., Shen, J., Lydon, C., Yeap, B. Y., Sholl, L. M., Johnson, B. E., & Jänne, P. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0657 · Cited by 372
Self-citationMazières, J., Zalcman, G., Crinò, L., Biondani, P., Barlesi, F., Filleron, T., Dingemans, A.-M. C., Léna, H., Monnet, I., Rothschild, S. I., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.3302 · Cited by 369
c-MET as a potential therapeutic target and biomarker in cancer
Sierra, J. R., & Tsao, M.-S. (2011) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834011422557 · Cited by 365
Self-citationRekhtman, N., Paik, P. K., Arcila, M. E., Tafe, L. J., Oxnard, G. R., Moreira, A. L., Travis, W. D., Zakowski, M. F., Kris, M. G., & Ladanyi, M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2109 · Cited by 364
Self-citationJanjigian, Y. Y., Smit, E. F., Groen, H. J. M., Horn, L., Gettinger, S., Camidge, D. R., Riely, G. J., Wang, B., Fu, Y., Chand, V. K., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0326 · Cited by 362
Sepulveda, A. R., Hamilton, S. R., Allegra, C. J., Grody, W., Cushman-Vokoun, A. M., Funkhouser, W. K., Kopetz, S. E., Lieu, C., Lindor, N. M., Minsky, B. D., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.9807 · Cited by 360
Self-citationGautschi, O., Milia, J., Filleron, T., Wolf, J., Carbone, D. P., Owen, D., Camidge, R., Narayanan, V., Doebele, R. C., Besse, B., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.9352 · Cited by 360
Liu, X., Jia, Y., Stoopler, M. B., Shen, Y., Cheng, H., Chen, J., Mansukhani, M., Koul, S., Halmos, B., & Borczuk, A. C. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.0674 · Cited by 349
Jänne, P. A., van den Heuvel, M. M., Barlesi, F., Cobo, M., Mazieres, J., Crinò, L., Orlov, S., Blackhall, F., Wolf, J., Garrido, P., et al. (2017) · JAMA · doi:10.1001/jama.2017.3438 · Cited by 335
Taron, M., Ichinose, Y., Rosell, R., Mok, T., Massuti, B., Zamora, L., Mate, J. L., Manegold, C., Ono, M., Queralt, C., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2618 · Cited by 334
Kris, M. G., Camidge, D. R., Giaccone, G., Hida, T., Li, B. T., O'Connell, J., Taylor, I., Zhang, H., Arcila, M. E., Goldberg, Z., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv186 · Cited by 334
Self-citationSpigel, D. R., Edelman, M. J., O’Byrne, K., Paz-Ares, L., Mocci, S., Phan, S., Shames, D. S., Smith, D., Yu, W., Paton, V. E., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.2160 · Cited by 333
Increased plasma DNA integrity in cancer patients.
Wang, B. G., Huang, H. Y., Chen, Y., Bristow, R. E., Kassauei, K., Cheng, C., Roden, R. B. S., Sokoll, L. J., Chan, D. W., & Shih, I. (2003) · PubMed · Cited by 326
Lung Cancer Cell Lines Harboring MET Gene Amplification Are Dependent on Met for Growth and Survival
Lutterbach, B., Zeng, Q., Davis, L. J., Hatch, H., Hang, G., Kohl, N. E., Gibbs, J. B., & Pan, B.-S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3495 · Cited by 320
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation
Porta, R., Sánchez-Torres, J. M., Paz-Ares, L., Massutí, B., Reguart, N., Mayo, C., Lianes, P., Queralt, C., Guillem, V., Salinas, P., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00195609 · Cited by 316
Mao, C., Qiu, L.-X., Liao, R.-Y., Du, F.-B., Ding, H., Yang, W.-C., Li, J., & Chen, Q. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2009.11.020 · Cited by 313
Ellison, G., Zhu, G., Moulis, A., Dearden, S., Speake, G., & McCormack, R. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-201194 · Cited by 301
Kerr, K. M., Bubendorf, L., Edelman, M. J., Marchetti, A., Mok, T., Novello, S., O'Byrne, K., Stahel, R., Peters, S., Felip, E., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu145 · Cited by 298
Self-citationYoh, K., Seto, T., Satouchi, M., Nishio, M., Yamamoto, N., Murakami, H., Nogami, N., Matsumoto, S., Kohno, T., Tsuta, K., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30322-8 · Cited by 294
HER2 amplification and HER2 mutation are distinct molecular targets in lung cancers
Li, B. T., Ross, D. S., Aisner, D. L., Chaft, J. E., Hsu, M., Kako, S. L., Kris, M. G., Varella-Garcia, M., & Arcila, M. E. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.10.025 · Cited by 286
Leighl, N. B., Rekhtman, N., Biermann, W. A., Huang, J., Mino-Kenudson, M., Ramalingam, S. S., West, H., Whitlock, S., & Somerfield, M. R. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.3055 · Cited by 281
on behalf of the Hokkaido Lung Cancer Clinical Study Group, Asahina, H., Yamazaki, K., Kinoshita, I., Sukoh, N., Harada, M., Yokouchi, H., Ishida, T., Ogura, S., Kojima, T., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603393 · Cited by 277
Drilon, A., Wang, L., Arcila, M. E., Balasubramanian, S., Greenbowe, J. R., Ross, J. S., Stephens, P., Lipson, D., Miller, V. A., Kris, M. G., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2683 · Cited by 274
Self-citationPrognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma
Marks, J. L., Broderick, S., Zhou, Q., Chitale, D., Li, A. R., Zakowski, M. F., Kris, M. G., Rusch, V. W., Azzoli, C. G., Seshan, V. E., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318160c607 · Cited by 268
Self-citationHirsch, F. R., Varella-Garcia, M., Cappuzzo, F., McCoy, J., Bemis, L., Xavier, A. C., Dziadziuszko, R., Gumerlock, P., Chansky, K., West, H., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm003 · Cited by 268
Self-citationLi, S., Li, L., Zhu, Y., Huang, C., Qin, Y., Liu, H., Ren-Heidenreich, L., Shi, B., Ren, H., Chu, X., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.210 · Cited by 243
Yu, H. A., Tian, S. K., Drilon, A. E., Borsu, L., Riely, G. J., Arcila, M. E., & Ladanyi, M. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1066 · Cited by 240
Self-citationMechanisms of Acquired Resistance to AZD9291
Kim, T. M., Song, A., Kim, D.-W., Kim, S., Ahn, Y.-O., Keam, B., Jeon, Y. K., Lee, S.-H., Chung, D. H., & Heo, D. S. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000688 · Cited by 222
Luo, J., Shen, L., & Zheng, D. (2014) · Scientific Reports · doi:10.1038/srep06269 · Cited by 212
McLeer-Florin, A., Moro-Sibilot, D., Melis, A., Salameire, D., Lefebvre, C., Ceccaldi, F., de Fraipont, F., Brambilla, E., & Lantuejoul, S. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182381535 · Cited by 205
Dietel, M., Bubendorf, L., Dingemans, A.-M. C., Dooms, C., Elmberger, G., García, R. C., Kerr, K. M., Lim, E., López-Ríos, F., Thunnissen, E., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2014-206677 · Cited by 203
Self-citationBlackhall, F. H., Peters, S., Bubendorf, L., Dafni, U., Kerr, K. M., Hager, H., Soltermann, A., O'Byrne, K. J., Dooms, C., Sejda, A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.5921 · Cited by 194
Self-citationWang, S., Tsui, S. T., Liu, C., Song, Y., & Liu, D. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0290-1 · Cited by 194
ROS1 Immunohistochemistry for Detection of ROS1-Rearranged Lung Adenocarcinomas
Sholl, L. M., Sun, H., Butaney, M., Zhang, C., Lee, C., Jänne, P. A., & Rodig, S. J. (2013) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182960fa7 · Cited by 187
Self-citationSuehara, Y., Arcila, M., Wang, L., Hasanovic, A., Ang, D., Ito, T., Kimura, Y., Drilon, A., Guha, U., Rusch, V., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0838 · Cited by 180
Self-citationHata, A., Katakami, N., Yoshioka, H., Takeshita, J., Tanaka, K., Nanjo, S., Fujita, S., Kaji, R., Imai, Y., Monden, K., et al. (2013) · Cancer · doi:10.1002/cncr.28364 · Cited by 178
Ludovini, V., Bianconi, F., Pistola, L., Chiari, R., Minotti, V., Colella, R., Giuffrida, D., Tofanetti, F. R., Siggillino, A., Flacco, A., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31820a3a6b · Cited by 177
Boland, J. M., Erdogan, S., Vasmatzis, G., Yang, P., Tillmans, L. S., Johnson, M. R. E., Wang, X., Peterson, L. M., Halling, K. C., Oliveira, A. M., et al. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.01.012 · Cited by 174
Noonan, S. A., Berry, L., Lu, X., Gao, D., Barón, A. E., Chesnut, P., Sheren, J., Aisner, D. L., Merrick, D., Doebele, R. C., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.04.033 · Cited by 173
Self-citationKim, H., Yoo, S.-B., Choe, J.-Y., Paik, J. H., Xu, X., Nitta, H., Zhang, W., Grogan, T. M., Lee, C.-T., Jheon, S., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31821cfc73 · Cited by 163
Sholl, L. M., Weremowicz, S., Gray, S. W., Wong, K.-K., Chirieac, L. R., Lindeman, N. I., & Hornick, J. L. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31827db604 · Cited by 162
Self-citationTuononen, K., Mäki‐Nevala, S., Sarhadi, V. K., Wirtanen, A., Rönty, M., Salmenkivi, K., Andrews, J. M., Telaranta‐Keerie, A. I., Hannula, S., Lagström, S., et al. (2013) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.22047 · Cited by 160
Pekar‐Zlotin, M., Hirsch, F. R., Soussan‐Gutman, L., Ilouze, M., Dvir, A., Boyle, T. A., Wynes, M. W., Miller, V. A., Lipson, D., Palmer, G. A., et al. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0389 · Cited by 159
Self-citationValidation of New Cancer Biomarkers: A Position Statement from the European Group on Tumor Markers
Duffy, M. J., Sturgeon, C. M., Sölétormos, G., Barak, V., Molina, R., Hayes, D. F., Diamandis, E. P., & Bossuyt, P. M. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.239863 · Cited by 159
Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers
Yoshida, A., Tsuta, K., Wakai, S., Arai, Y., Asamura, H., Shibata, T., Furuta, K., Kohno, T., & Kushima, R. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.192 · Cited by 157
Dziadziuszko, R., Wynes, M. W., Singh, S., Asuncion, B. R., Ranger‐Moore, J., Konopa, K., Rzyman, W., Szostakiewicz, B., Jassem, J., & Hirsch, F. R. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318240ca0d · Cited by 156
Self-citationc-MET/Phospho-MET Protein Expression and MET Gene Copy Number in Non-small Cell Lung Carcinomas
Tsuta, K., Kozu, Y., Mimae, T., Yoshida, A., Kohno, T., Sekine, I., Tamura, T., Asamura, H., Furuta, K., & Tsuda, H. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318241655f · Cited by 152
Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers
Tomizawa, K., Suda, K., Onozato, R., Kosaka, T., Endoh, H., Sekido, Y., Shigematsu, H., Kuwano, H., Yatabe, Y., & Mitsudomi, T. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.01.014 · Cited by 151
Cabillic, F., Gros, A., Dugay, F., Bégueret, H., Mesturoux, L., Chiforeanu, D. C., Dufrenot-Petitjean-Roget, L., Jauffret, V., Dachary, D., Corre, R., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000072 · Cited by 151
Clinicopathological features of nonsmall cell lung carcinomas with BRAF mutations
Kinno, T., Tsuta, K., Shiraishi, K., Mizukami, T., Suzuki, M., Yoshida, A., Suzuki, K., Asamura, H., Furuta, K., Kohno, T., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt495 · Cited by 148
Frequency of EGFR and KRAS Mutations in Lung Adenocarcinomas in African Americans
Reinersman, J. M., Johnson, M. L., Riely, G. J., Chitale, D. A., Nicastri, A. D., Soff, G. A., Schwartz, A. G., Sima, C. S., Ayalew, G. D., Lau, C., et al. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181fb4fe2 · Cited by 147
Self-citationLiu, L., Shao, X., Gao, W., Bai, J., Wang, R., Huang, P., Yin, Y., Liu, P., & Shu, Y. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181f26266 · Cited by 146
Worse Disease-Free Survival in Never-Smokers with ALK+ Lung Adenocarcinoma
Yang, P., Kulig, K., Boland, J. M., Erickson‐Johnson, M. R., Oliveira, A. M., Wampfler, J. A., Jatoi, A., Deschamps, C. C., Marks, R. S., Fortner, C., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31823c5c32 · Cited by 142
Koeppen, H., Yu, W., Zha, J., Pandita, A., Penuel, E. M., Rangell, L. K., Raja, R. G., Mohan, S., Patel, R., Desai, R. M., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1836 · Cited by 142
Wang, Z., Chen, R., Wang, S., Zhong, J., Wu, M., Zhao, J., Duan, J., Zhuo, M., An, T., Wang, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110780 · Cited by 138
Meng, D., Yuan, M., Li, X., Chen, L., Yang, J., Zhao, X., Ma, W., & Xin, J. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.03.019 · Cited by 137
Sunaga, N., Tomizawa, Y., Yanagitani, N., Iijima, H., Kaira, K., Shimizu, K., Tanaka, S., Suga, T., Hisada, T., Ishizuka, T., et al. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.01.025 · Cited by 135
Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma
Lee, S. E., Lee, B., Hong, M. E., Song, J., Jung, K., Lira, M. E., Mao, M., Han, J., Kim, J., & Choi, Y. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.107 · Cited by 131
Marchetti, A., Lorito, A. D., Pace, M. V., Iezzi, M., Felicioni, L., D’Antuono, T., Filice, G., Guetti, L., Mucilli, F., & Buttitta, F. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.12.111 · Cited by 130
Hsu, K.-H., Ho, C., Hsia, T., Tseng, J., Su, K., Wu, M., Chiu, K.-L., Yang, T., Chen, K.-C., Ooi, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120852 · Cited by 128
Ying, J., Guo, L., Qiu, T., Shan, L., Ling, Y., Liu, X., & Lü, N. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt295 · Cited by 128
Kim, H. R., Lim, S., Kim, H. J., Hwang, S., Park, J. K., Shin, E., Bae, M., Ou, S.-H. I., Wang, J., Jewell, S. S., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt220 · Cited by 128
Sun, J., Ahn, M., Choi, Y., Ahn, J. S., & Park, K. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.08.023 · Cited by 127
Immunohistochemical Detection of EGFR Mutation Using Mutation-Specific Antibodies in Lung Cancer
Kitamura, A., Hosoda, W., Sasaki, E., Mitsudomi, T., & Yatabe, Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0129 · Cited by 124
Self-citationALK Status Testing in Non–Small Cell Lung Carcinoma
Minca, E. C., Portier, B. P., Wang, Z., Lanigan, C. P., Farver, C. F., Feng, Y., Ma, P. C., Arrossi, V., Pennell, N. A., & Tubbs, R. R. (2013) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.01.004 · Cited by 122
On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas
Mescam-Mancini, L., Lantuéjoul, S., Moro‐Sibilot, D., Rouquette, I., Souquet, P.-J., Audigier-Valette, C., Sabourin, J., Decroisette, C., Sakhri, L., Brambilla, E. M., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.11.019 · Cited by 122
MET Exon 14 Skipping in Non-Small Cell Lung Cancer
Heist, R. S., Shim, H. S., Gingipally, S., Mino-Kenudson, M. A., Le, L. P., Gainor, J. F., Zheng, Z., Aryee, M. J., Xia, J., Jia, P., et al. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0510 · Cited by 121
A Prospective PCR-Based Screening for the EML4-ALK Oncogene in Non–Small Cell Lung Cancer
Soda, M., Isobe, K., Inoue, A., Maemondo, M., Oizumi, S., Fujita, Y., Gemma, A., Yamashita, Y., Ueno, T., Takeuchi, K., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2947 · Cited by 120
Molina‐Vila, M. Á., Bertrán-Alamillo, J., Reguart, N., Tarón, M., Castellà, E., Llatjós, M., Costa, C., Mayo, C., Pradas, A., Queralt, C., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318189f579 · Cited by 119
Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomas
Đačić, S., Shuai, Y., Yousem, S. A., Ohori, P. N., & Nikiforova, M. N. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.154 · Cited by 116
Scarpa, A., Sikora, K. O., Fassan, M., Rachiglio, A. M., Cappellesso, R., Antonello, D., Amato, E., Mafficini, A., Lambiase, M., Esposito, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080478 · Cited by 116
Screening for EGFR mutations in lung cancer, a report from India
Sahoo, R., Harini, V. V., Babu, V. C., Okaly, G. V. P., Rao, S., Nargund, A. R., Venkataswamy, E., Rao, R., & Kumar, B. S. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.01.004 · Cited by 116
Ilié, M., Long-Mira, É., Hofman, V., Dadone‐Montaudié, B., Marquette, C., Mouroux, J., Vignaud, J.-M., Bégueret, H., Merlio, J., Capper, D., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds534 · Cited by 116
Nomogram to predict the presence ofEGFRactivating mutation in lung adenocarcinoma
Girard, N., Sima, C. S., Jackman, D. M., Sequist, L. V. D., Chen, H., Yang, J. C., Ji, H., Waltman, B. A., Rosell, R., Tarón, M., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00010111 · Cited by 114
Self-citationEndris, V., Penzel, R., Warth, A., Muckenhuber, A., Schirmacher, P., Stenzinger, A., & Weichert, W. (2013) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.06.002 · Cited by 113
Sholl, L. M., Aisner, D. L., Allen, T. C., Beasley, M. B., Borczuk, A., Cagle, P. T., Capelozzi, V. L., Đačić, S., Hariri, L. P., Kerr, K. M., et al. (2016) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2015-0506-sa · Cited by 113
Self-citationLi, H., Pan, Y., Li, Y., Li, C., Wang, R., Hu, H., Zhang, Y., Ye, T., Wang, L., Shen, L., et al. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.09.018 · Cited by 112
Park, H. S., Lee, J. J.-K., Kim, D., Kulig, K., Kim, T. M., Lee, S., Jeon, Y., Chung, D. H., & Heo, D. S. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.03.004 · Cited by 111
BRAF-mutations in non-small cell lung cancer
Brustugun, O. T., Khattak, A. M., Trømborg, A. K., Beigi, M., Beiske, K., Lund‐Iversen, M., & Helland, Å. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.01.023 · Cited by 110
Ilié, M., Bence, C., Hofman, V., Long-Mira, É., Butori, C., Bouhlel, L., Lalvée, S., Mouroux, J., Poudenx, M., Otto, J., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu484 · Cited by 110
Warth, A., Muley, T., Dienemann, H., Goeppert, B. F., Stenzinger, A., Schnabel, P. A., Schirmacher, P., Penzel, R., & Weichert, W. (2014) · Histopathology · doi:10.1111/his.12379 · Cited by 107
Shan, L., Lian, F., Guo, L., Qiu, T., Ling, Y., Ying, J., & Lin, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120422 · Cited by 103
Prognostic and predictive biomarkers in lung cancer. A review
Thunnissen, E., der Oord, K. V., & den Bakker, M. (2014) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-014-1535-4 · Cited by 103
Self-citationERBB2 -Mutated Metastatic Non–Small Cell Lung Cancer: Response and Resistance to Targeted Therapies
Chuang, J. C., Stehr, H., Liang, Y., Das, M. S., Huang, J. Q., Diehn, M., Wakelee, H. A., & Neal, J. W. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.01.023 · Cited by 102
Li, C., Sun, Y., Fang, R., Han, X., Luo, X., Wang, R., Pan, Y., Hu, H., Zhang, Y., Pao, W. J., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318234f0a2 · Cited by 100
A Patient with Lung Adenocarcinoma and RET Fusion Treated with Vandetanib
Gautschi, O. P., Zander, T., Aebersold, F., Strobel, K., Hirschmann, A., Aebi, S. P., & Diebold, J. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31828a4d07 · Cited by 100
Tang, X., Varella‐Garcia, M., Xavier, A. C., Massarelli, E., Ozburn, N. C., Moran, C. A., & Wistuba, I. I. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0032 · Cited by 99
MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer
Feng, Y., Thiagarajan, P. S., & Ma, P. C. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182417e44 · Cited by 98
Leidner, R. S., Fu, P., Clifford, B. T., Hamdan, A., Jin, C., Eisenberg, R., Boggon, T. J., Skokan, M. C., Franklin, W. A., Cappuzzo, F., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.1431 · Cited by 98
Self-citationScheffler, M., Schultheis, A. M., Teixidó, C., Michels, S. Y. F., Morales-Espinosa, D., Viteri, S., Hartmann, W., Merkelbach‐Bruse, S., Fischer, R. N., Schildhaus, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3387 · Cited by 96
Yoshizawa, A., Sumiyoshi, S., Sonobe, M., Kobayashi, M., Uehara, T., Fujimoto, M., Tsuruyama, T., Date, H., & Haga, H. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.06.007 · Cited by 96
Alì, G., Proietti, A., Pelliccioni, S., Niccoli, C., Lupi, C., Sensi, E., Giannini, R., Borrelli, N., Menghi, M., Chella, A., et al. (2014) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2013-0388-oa · Cited by 95
Sugio, K., Uramoto, H., Onitsuka, T., Mizukami, M., Ichiki, Y., Sugaya, M., Yasuda, M., Takenoyama, M., Oyama, T., Hanagiri, T., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.09.010 · Cited by 95
ROS1 fusions in Chinese patients with non-small-cell lung cancer
Cai, W., Li, X., Su, C., Fan, L., Zheng, L.-M., Fei, K., Zhou, C., Manegold, C., & Schmid‐Bindert, G. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt071 · Cited by 90
Carter, C. A., Rajan, A., Keen, C., Szabo, E. M., Khozin, S., Thomas, A., Brzezniak, C. E., Guha, U., Doyle, L. A., Steinberg, S. M., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw008 · Cited by 90
Chen, Y., Hsieh, M., Wu, S., Chang, Y., Shih, J., Liu, Y., Tsai, M., Tsai, T.-H., Yu, C., Yang, J. C., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000232 · Cited by 86
Krug, L. M., Miller, V. A., Patel, J. D., Crapanzano, J. P., Azzoli, C. G., Gomez, J. E., Kris, M. G., Heelan, R. T., Pizzo, B., Tyson, L. B., et al. (2005) · Cancer · doi:10.1002/cncr.21428 · Cited by 84
Gainor, J. F., Niederst, M. J., Lennerz, J. K., Dagogo‐Jack, I., Stevens, S. E., Shaw, A. T., Sequist, L. V. D., & Engelman, J. A. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.02.021 · Cited by 84
EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients
Bae, N. C., Chae, M. H., Lee, M. H., Kim, K. M., Lee, E. B., Kim, C. H., Park, T. I., Han, S. B., Jheon, S., Jung, T. H., et al. (2007) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2006.10.007 · Cited by 82
Cutz, J., Craddock, K. J., Torlakovic, E., Brandao, G., Carter, R. F., Bigras, G., Deschênes, J., Izevbaye, I., Xu, Z., Greer, W. L., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000239 · Cited by 82
Self-citationWu, C., Hsu, H., Liu, H., Chang, J. W., Chen, Y., Hsieh, W.-Y., Hsieh, J., Hsieh, M., Chen, Y., & Huang, S. (2008) · Cancer · doi:10.1002/cncr.23925 · Cited by 82
Coté, M. L., Haddad, R., Edwards, D. J., Atikukke, G., Gadgeel, S. M., Soubani, A. O., Lonardo, F., Bepler, G., Schwartz, A. G., & Ethier, S. P. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31820a0ec0 · Cited by 81
Sakai, K., Horiike, A., Irwin, D. L., Kudo, K., Fujita, Y., Tanimoto, A., Sakatani, T., Saito, R., Kaburaki, K., Yanagitani, N., et al. (2013) · Cancer Science · doi:10.1111/cas.12211 · Cited by 81
Li, F., Feng, Y., Fang, R., Fang, Z., Xia, J., Han, X., Liu, X., Chen, H., Liu, H., & Ji, H. (2012) · Cell Research · doi:10.1038/cr.2012.27 · Cited by 79
Thu, K. L., Vucic, E. A., Chari, R., Zhang, W., Lockwood, W. W., English, J. C., Fu, R., Wang, P., Feng, Z., MacAulay, C. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033003 · Cited by 78
Guo, B., Cen, H., Tan, X., Liu, W., & Ke, Q. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099399 · Cited by 77
Suzuki, M., Shiraishi, K., Yoshida, A., Shimada, Y., Suzuki, K., Asamura, H., Furuta, K., Kohno, T., & Tsuta, K. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.10.014 · Cited by 77
Muers, M. F., & Haward, R. (1996) · Thorax · doi:10.1136/thx.51.6.557 · Cited by 76
Genomic Profiles Specific to Patient Ethnicity in Lung Adenocarcinoma
Broët, P., Dalmasso, C., Tan, E. H., Alifano, M., Zhang, S., Wu, J., Lee, M. H., Régnard, J., Lim, W., Koong, H. N., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2185 · Cited by 76
Cha, Y. J., Lee, J. S., Kim, H. R., Lim, S. M., Cho, B. C., Lee, C. Y., & Shim, H. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103333 · Cited by 76
Savic, S., Diebold, J., Zimmermann, A., Jochum, W., Baschiera, B., Grieshaber, S., Tornillo, L., Bisig, B., Kerr, K. M., & Bubendorf, L. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.05.012 · Cited by 75
Self-citationThe Next Wave of EGFR Tyrosine Kinase Inhibitors Enter the Clinic
Politi, K. A., Ayeni, D. O., & Lynch, T. J. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.05.012 · Cited by 74
Wiesweg, M., Eberhardt, W., Reis, H., Ting, S. C., Savvidou, N., Skiba, C., Herold, T., Christoph, D. C., Meiler, J., Worm, K., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.08.137 · Cited by 71
To, K., TONG, J. H. M., Yeung, K. S., Lung, R. W. M., Law, P. P. Y., Chau, S. L., Kang, W., Tong, C. Y., Chow, C., Chan, A. W. H., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182904e22 · Cited by 70
Gridelli, C., Balducci, L., Ciardiello, F., Maïo, M. D., Felip, E., Langer, C. J., Lilenbaum, R., Perrone, F., Senan, S., & de Marinis, F. (2015) · Clinical Lung Cancer · doi:10.1016/j.cllc.2015.02.006 · Cited by 70
Yeung, S. F., TONG, J. H. M., Law, P. P. Y., Chung, L. Y., Lung, R. W. M., Tong, C. Y., Chow, C., Chan, A. W. H., Wan, I. Y. P., Mok, T. S. K., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000620 · Cited by 70
Joseph, L. J., Cankovic, M., Caughron, S. K., Chandra, P., Emmadi, R., Hagenkord, J. M., Hallam, S., Jewell, K. E., Klein, R. D., Pratt, V. M., et al. (2016) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2016.05.007 · Cited by 70
Self-citationLee, Y. J., Park, I. K., Park, M. S., Choi, H. J., Cho, B. C., Chung, K. S., Kim, S. K., Chang, J., Moon, J. W., Kim, H., et al. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0611-7 · Cited by 69
Hotta, K., Kiura, K., Toyooka, S., Takigawa, N., Soh, J., Fujiwara, Y., Tabata, M., Date, H., & Tanimoto, M. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318074bc0d · Cited by 68
Guibert, N. M., Barlési, F., Descourt, R., Léna, H., Besse, B., Beau‐Faller, M., Mosser, J., Pichon, É., Merlio, J., Ouafik, L., et al. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.02.001 · Cited by 68
Conde, E., Suárez‐Gauthier, A., Benito, A., Garrido, P., García‐Campelo, R., Biscuola, M., Paz-Ares, L. G., Hardisson, D., de Castro, J., Camacho, M. C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107200 · Cited by 67
Go, H., Kim, D., Kim, D., Keam, B., Kim, T. M., Lee, S., Heo, D. S., Bang, Y., & Chung, D. H. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182a4dd6e · Cited by 66
Haneda, H., Sasaki, H., Lindeman, N. I., Kawano, O., Endo, K., Suzuki, E., Shimizu, S., Yukiue, H., Kobayashi, Y., Yano, M., et al. (2006) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyi228 · Cited by 66
Self-citationLayfield, L. J., Roy‐Chowdhuri, S., Baloch, Z. W., Ehya, H., Geisinger, K. R., Hsiao, S. J., Lin, O., Lindeman, N. I., Roh, M. H., Schmitt, F. C., et al. (2016) · Diagnostic Cytopathology · doi:10.1002/dc.23549 · Cited by 66
Self-citationROS1 Immunohistochemistry Among Major Genotypes of Non–Small-Cell Lung Cancer
Boyle, T. A., Masago, K., Ellison, K. E., Yatabe, Y., & Hirsch, F. R. (2014) · Clinical Lung Cancer · doi:10.1016/j.cllc.2014.10.003 · Cited by 65
Self-citationSasaki, H., Endo, K., Okuda, K., Kawano, O., Kitahara, N., Tanaka, H., Matsumura, A., Iuchi, K., Takada, M., Kawahara, M., et al. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0320-z · Cited by 64
Kukita, Y., Uchida, J., Oba, S., Nishino, K., Kumagai, T., Taniguchi, K., Okuyama, T., Imamura, F., & Kato, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081468 · Cited by 64
Fiala, O., Pešek, M., Fínek, J., Benešová, L., Belšánová, B., & Minárik, M. (2013) · Cancer Genetics · doi:10.1016/j.cancergen.2012.12.003 · Cited by 64
Caparica, R., Yen, C. T., Coudry, R. A., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.09.116 · Cited by 64
Jurmeister, P. S., Lenze, D., Berg, E. G., Mende, S., Schäper, F., Kellner, U., Herbst, H., Sers, C., Budczies, J., Dietel, M., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.11.018 · Cited by 63
Hutarew, G., Hauser‐Kronberger, C., Strasser, F., Llenos, I. C., & Dietze, O. (2014) · Histopathology · doi:10.1111/his.12399 · Cited by 62
SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015
García‐Campelo, R., Bernabé, R., Cobo, M., Corral, J., Coves, J., Dómine, M., Nadal, E., Rodríguez‐Abreu, D., Viñolas, N., & Massutí, B. (2015) · Clinical & Translational Oncology · doi:10.1007/s12094-015-1455-z · Cited by 62
Uramoto, H., Sugio, K., Oyama, T., Ono, K., Sugaya, M., Yoshimatsu, T., Hanagiri, T., Morita, M., & Yasumoto, K. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.08.006 · Cited by 61
Cited by
Drilon, A., Siena, S., Dziadziuszko, R., Barlesi, F., Krebs, M. G., Shaw, A. T., de Braud, F., Rolfo, C., Ahn, M.-J., Wolf, J., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30690-4 · Cited by 528
Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
Testa, U., Castelli, G., & Pelosi, E. (2018) · Cancers · doi:10.3390/cancers10080248 · Cited by 403
EGFR signaling pathway as therapeutic target in human cancers
Levantini, E., Maroni, G., Del Re, M., & Tenen, D. G. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.04.002 · Cited by 356
The current state of molecular testing in the treatment of patients with solid tumors, 2019
El‐Deiry, W. S., Goldberg, R. M., Lenz, H., Shields, A. F., Gibney, G. T., Tan, A. R., Brown, J., Eisenberg, B., Heath, E. I., Phuphanich, S., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21560 · Cited by 264
Metadata
- Authors
- Lindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E. H., Colasacco, C., Dacic, S., Hirsch, F. R., Kerr, K., Kwiatkowski, D. J., Ladanyi, M., Nowak, J. A., Sholl, L., Temple-Smolkin, R., Solomon, B., Souter, L. H., Thunnissen, E., Tsao, M. S., Ventura, C. B., Wynes, M. W., & Yatabe, Y.
- Venue
- The Journal of Molecular Diagnostics
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 20
- Issue
- 2
- Pages
- 129-159
- ISSN
- 1525-1578 (ISSN-L)
- OpenAlex
- W2785259638
- Cited by
- 346
- References
- 240
- FWCI
- 30.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.